OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Congenital Heart Futures Reauthorization Act of 2017

Floor Speech

Date: Dec. 19, 2018
Location: Washington, DC
Issues: Health and Health Care

BREAK IN TRANSCRIPT

Mr. Speaker, I rise in support of the Senate amendment to H.R. 1222, the Congenital Heart Futures Reauthorization Act led by Congressman Bilirakis and Congressman Schiff.

This legislation builds on the success of current efforts by the Centers for Disease Control and Prevention to improve and expand research, surveillance, and public outreach and education programs relating to congenital heart disease.

Each year more than 40,000 babies are born in the United States with a congenital heart defect, and 1 million children and 1.4 million adults are currently living with congenital heart disorders.

Even though congenital heart disease is the most common birth defect in America, there are still many unknowns surrounding the condition.

This legislation will help expand our understanding of congenital heart disease across the lifespan, and has the potential to improve the lives of the millions of children and adults living with congenital heart disease.

BREAK IN TRANSCRIPT

Mr. TONKO. Mr. Speaker, in closing, I echo my support for the Senate amendment to H.R. 1222, it is worthy of our support. We will continue to build on the research and education concerning birth defects, and, most importantly, we will enable individuals and families who live with birth defects to have more hope.

BREAK IN TRANSCRIPT


Source
arrow_upward